Colgate-Palmolive Company reported total net sales of $5.32 billion for the first quarter of fiscal 2026, representing an 8.4% increase year-over-year. On a GAAP basis, diluted EPS decreased 6% to $0.80, while non-GAAP base business diluted EPS increased 7% to $0.97, beating market consensus estimates. Financial performance was primarily driven by a 2.9% expansion in organic sales, supported by positive volume and pricing growth across four of its five operating divisions, with exceptional momentum in Latin America and Europe helping to offset higher raw material costs and increased advertising outlays.
Note: Colgate-Palmolive's FY'25 ended on December 31, 2025. Q1 FY'26 ended on March 31, 2026.
Colgate-Palmolive expanded its global Strategic Growth and Productivity Program to optimize its manufacturing footprint and supply chain network. The company raised its estimated cumulative pretax charges for the program to a range of 350 million dollars to 550 million dollars, aiming to generate long-term annualized savings of 200 million dollars to 300 million dollars once fully implemented, while simultaneously appointing Samir Singh as President of Enterprise Oral Care to drive innovation across its core category.
Below are key drivers of Colgate-Palmolive's value that present opportunities for upside or downside to the current Trefis price estimate:
For additional details, select a division from the interactive Trefis split for Colgate-Palmolive at the top of the page.
Colgate-Palmolive Company operates as a leading global consumer products enterprise, manufacturing and marketing a wide array of oral care, personal care, home care, and pet nutrition products across worldwide retail and commercial channels.
The Oral, Personal and Home Care division remains the foundational engine of the company's valuation due to its unmatched retail distribution scale and highly resilient consumer demand dynamics.
The company maintains an elite brand presence with the Colgate trademark being one of the most widely purchased consumer staples in the world, providing unmatched negotiating leverage with global retailers and distributors.
Colgate consistently shifts its product mix toward therapeutic, whitening, and sensitive variants, enabling the firm to execute precise pricing increases that defend operational gross margins against localized currency and commodity pressures.
Global retail consumption trends continue to favor value-added personal care products with specialized health benefits, prompting staples manufacturers to aggressively boost advertising investments and scale clinical product lines.
Management is focusing its core operational strategy on expanding digital capabilities, utilizing advanced artificial intelligence pricing systems and productivity initiatives to maximize enterprise returns and sustain long-term earnings per share growth.
